专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

21. 发明授权

US06307090B1 Acylated oligopeptide derivatives having cell signal inhibiting activity 有权
标题翻译：具有细胞信号抑制活性的酰化寡肽衍生物
公开(公告)号：US06307090B1
公开(公告)日：2001-10-23
申请号：US09236160
申请日：1999-01-22
申请人： Terrence R. Burke, Jr. , Zhu-jun Yao , C. Richter King
发明人： Terrence R. Burke, Jr. , Zhu-jun Yao , C. Richter King
IPC分类号： C07C6976
CPC分类号： C07F9/3882 , A61K38/00 , C07C233/56 , C07F9/12
摘要： The invention relates to an acylated peptide, namely a compound of formula (I), wherein n is 0 to 15, X is oxalyl PTI is the bivalent radical of tyrosine or (preferably) the bivalent radical of phosphotyrosine or a phosphotyrosine mimetic, AA stands for a bivalent radical of a natural or unnatural amino acid, and Y is secondary amino group, or a salt thereof, said compound being useful for the treatment of diseases that respond to inhibition of the interaction of (a) protein(s) comprising (an) SH2 domain(s) and a protein tyrosine kinase or a modified version thereof.
摘要翻译：本发明涉及酰化肽，即式（I）化合物，其中n为0至15，X为草酰基PTI为酪氨酸的二价基团或（优选）磷酸酪氨酸或磷酸酪氨酸模拟物的二价基团，AA代表天然或非天然氨基酸的二价基团，Y是仲氨基或其盐，所述化合物可用于治疗对（a）蛋白质的相互作用的抑制作用的疾病的治疗，所述蛋白质包含（a） SH2结构域和蛋白质酪氨酸激酶或其修饰形式。

22. 发明申请

US20140314809A1 MALARIA ANTIGEN SCREENING METHOD 审中-公开
标题翻译： MALARIA抗原筛选方法
公开(公告)号：US20140314809A1
公开(公告)日：2014-10-23
申请号：US13866116
申请日：2013-04-19
申请人： Joseph T. Bruder , Imre Kovesdi , Duncan L. McVey , Douglas E. Brough , C. Richter King , Denise Louise Doolan , Joao Carlos Aguair , Daniel John Carucci , Martha Sedegah , Walter R. Weiss , Keith Limbach
发明人： Joseph T. Bruder , Imre Kovesdi , Duncan L. McVey , Douglas E. Brough , C. Richter King , Denise Louise Doolan , Joao Carlos Aguair , Daniel John Carucci , Martha Sedegah , Walter R. Weiss , Keith Limbach
IPC分类号： G01N33/50
CPC分类号： G01N33/505
摘要： The invention provides a method of identifying an antigen from a pathogen or a disease antigen comprising the use of an adenoviral vector array comprising two or more different adenoviral vectors, wherein each adenoviral vector comprises a nucleic acid sequence encoding a different antigen of a pathogen. The adenoviral vectors are administered to antigen presenting cells (APCs) in vitro or to an animal in vivo. The immunogenicity of the antigen is measured by screening for an immune response from effector T lymphocytes in vitro and by screening for the absence of pathogen-induced disease onset in vivo.
摘要翻译：本发明提供了鉴定来自病原体或疾病抗原的抗原的方法，其包括使用包含两种或多种不同腺病毒载体的腺病毒载体阵列，其中每个腺病毒载体包含编码病原体的不同抗原的核酸序列。腺病毒载体在体外或动物体内施用于抗原呈递细胞（APC）。通过体外筛选来自效应T淋巴细胞的免疫应答并通过筛选在体内不存在病原体诱发的疾病来测量抗原的免疫原性。

23. 发明授权

US08454972B2 Method for inducing a multiclade immune response against HIV utilizing a multigene and multiclade immunogen 失效
标题翻译：使用多基因和多重免疫原诱导针对HIV的多重免疫应答的方法
公开(公告)号：US08454972B2
公开(公告)日：2013-06-04
申请号：US13010141
申请日：2011-01-20
申请人： Gary J. Nabel , Ling Xu , Bimal Chakrabarti , Lan Wu , Zhi-yong Yang , Jason G. D. Gall , C. Richter King , Zengguang Wang
发明人： Gary J. Nabel , Yue Huang , Ling Xu , Bimal Chakrabarti , Lan Wu , Zhi-yong Yang , Jason G. D. Gall , C. Richter King
IPC分类号： A61K39/21 , A61K39/295 , C07H21/04
CPC分类号： A61K39/21 , A61K39/00 , A61K39/12 , A61K2039/53 , A61K2039/54 , A61K2039/545 , A61K2039/57 , A61K2039/70 , C07K14/005 , C12N2740/16122 , C12N2740/16134 , C12N2740/16171 , C12N2740/16222 , C12N2740/16234 , C12N2740/16271 , C12N2740/16322 , C12N2740/16334 , C12N2740/16371
摘要： The present disclosure provides compositions for eliciting an immune response, including a prophylactic immune response, against human immunodeficiency virus. The composition includes nucleic acid constructs encoding HIV antigenic polypeptides of multiple clades or strains. Methods for eliciting an immune response by administering the composition to a subject are also provided.
摘要翻译：本公开提供了针对人类免疫缺陷病毒引发免疫应答（包括预防性免疫应答）的组合物。该组合物包括编码多个进化枝或菌株的HIV抗原多肽的核酸构建体。还提供了通过将受试者施用组合物引起免疫应答的方法。

24. 发明申请

US20120302627A1 METHOD OF USING ADENOVIRAL VECTORS TO INDUCE AN IMMUNE RESPONSE 审中-公开
标题翻译：使用腺病毒载体诱导免疫应答的方法
公开(公告)号：US20120302627A1
公开(公告)日：2012-11-29
申请号：US13568239
申请日：2012-08-07
申请人： Gary J. Nabel , Cheng Cheng , Wing-Pui Kong , Jason G.D. Gall , C. Richter King
发明人： Gary J. Nabel , Cheng Cheng , Wing-Pui Kong , Jason G.D. Gall , C. Richter King
IPC分类号： A61K31/7088 , A61P37/02
CPC分类号： C07K14/005 , A61K39/12 , A61K39/21 , A61K2039/5256 , A61K2039/53 , A61K2039/54 , A61K2039/545 , A61K2039/57 , C12N7/00 , C12N15/86 , C12N2710/10343 , C12N2740/16122 , C12N2740/16134 , C12N2740/16222 , C12N2740/16234
摘要： The invention provides a method of inducing an immune response against a human immunodeficiency virus (HIV) in a mammal. The method comprises administering to the mammal an adenoviral vector composition comprising one or more adenoviral vectors encoding two or more different HIV antigens, the production of which induces an immune response against HIV in the mammal. The invention also provides an adenoviral vector composition comprising four adenoviral vectors encoding an HIV clade A Env protein, an HIV clade B Env protein, an HIV clade C Env protein, and a fusion protein comprising an HIV clade B Gag protein and Pol protein, respectively.
摘要翻译：本发明提供一种在哺乳动物中诱导针对人类免疫缺陷病毒（HIV）的免疫应答的方法。该方法包括向哺乳动物施用腺病毒载体组合物，其包含编码两种或更多种不同HIV抗原的一种或多种腺病毒载体，其产生在哺乳动物中诱导针对HIV的免疫应答。本发明还提供一种腺病毒载体组合物，其包含分别编码HIV进化枝A Env蛋白，HIV进化枝B Env蛋白，HIV进化枝C Env蛋白和包含HIV进化枝B Gag蛋白和Pol蛋白的融合蛋白的四种腺病毒载体。

25. 发明申请

US20090214588A1 Vaccines against aids comprising cmv/r-nucleic acid constructs 审中-公开
标题翻译：针对包含cmv / r-核酸构建体的辅助剂的疫苗
公开(公告)号：US20090214588A1
公开(公告)日：2009-08-27
申请号：US11632522
申请日：2005-07-15
申请人： Gary J. Nabel , Yue Huang , Zengguang Wang , Ling Xu , Bimal Chakrabarti , Lan Wu , Zhi-yong Yang , Jason G.D. Gall , C. Richter King
发明人： Gary J. Nabel , Yue Huang , Zengguang Wang , Ling Xu , Bimal Chakrabarti , Lan Wu , Zhi-yong Yang , Jason G.D. Gall , C. Richter King
IPC分类号： A61K39/21 , C12N15/11 , C07K14/00
CPC分类号： A61K39/21 , A61K39/00 , A61K39/12 , A61K2039/53 , A61K2039/54 , A61K2039/545 , A61K2039/57 , A61K2039/70 , C07K14/005 , C12N2740/16122 , C12N2740/16134 , C12N2740/16171 , C12N2740/16222 , C12N2740/16234 , C12N2740/16271 , C12N2740/16322 , C12N2740/16334 , C12N2740/16371
摘要： The present disclosure provides compositions for eliciting an immune response, including a prophylactic immune response, against human immunodeficiency virus. The composition includes nucleic acid constructs encoding HIV antigenic polypeptides of multiple clades or strains. Methods for eliciting an immune response by administering the composition to a subject are also provided.
摘要翻译：本公开提供了针对人类免疫缺陷病毒引发免疫应答（包括预防性免疫应答）的组合物。该组合物包括编码多个进化枝或菌株的HIV抗原多肽的核酸构建体。还提供了通过将受试者施用组合物引起免疫应答的方法。

26. 发明申请

US20070207166A1 Method of Using Adenoviral Vectors to Induce an Immune Response 审中-公开
标题翻译：使用腺病毒载体诱导免疫反应的方法
公开(公告)号：US20070207166A1
公开(公告)日：2007-09-06
申请号：US11578096
申请日：2005-04-12
申请人： Gary Nabel , Cheng Cheng , Wing-Pui Kong , Jason Gall , C. Richter King
发明人： Gary Nabel , Cheng Cheng , Wing-Pui Kong , Jason Gall , C. Richter King
IPC分类号： A61K39/12 , C12N15/861
CPC分类号： C07K14/005 , A61K39/12 , A61K39/21 , A61K2039/5256 , A61K2039/53 , A61K2039/54 , A61K2039/545 , A61K2039/57 , C12N7/00 , C12N15/86 , C12N2710/10343 , C12N2740/16122 , C12N2740/16134 , C12N2740/16222 , C12N2740/16234
摘要： The invention provides a method of inducing an immune response against a human immunodeficiency virus (HIV) in a mammal. The method comprises administering to the mammal an adenoviral vector composition comprising one or more adenoviral vectors encoding two or more different HIV antigens, the production of which induces an immune response against HIV in the mammal. The invention also provides an adenoviral vector composition comprising four adenoviral vectors encoding an HIV clade A Env protein, an HIV clade B Env protein, an HIV clade C Env protein, and a fusion protein comprising an HIV clade B Gag protein and Pol protein, respectively.
摘要翻译：本发明提供一种在哺乳动物中诱导针对人类免疫缺陷病毒（HIV）的免疫应答的方法。该方法包括向哺乳动物施用腺病毒载体组合物，其包含编码两种或更多种不同HIV抗原的一种或多种腺病毒载体，其产生在哺乳动物中诱导针对HIV的免疫应答。本发明还提供一种腺病毒载体组合物，其包含分别编码HIV进化枝A Env蛋白，HIV进化枝B Env蛋白，HIV进化枝C Env蛋白和包含HIV进化枝B Gag蛋白和Pol蛋白的融合蛋白的四种腺病毒载体。

27. 发明授权

US07259142B2 Redox-stable, non-phosphorylated cyclic peptide inhibitors of SH2 domain binding to target protein, conjugates thereof, compositions and methods of synthesis and use 有权
标题翻译：与靶蛋白结合的SH2结构域的氧化还原稳定的非磷酸化环肽抑制剂，其结合物，组合物和合成和使用方法
公开(公告)号：US07259142B2
公开(公告)日：2007-08-21
申请号：US11224819
申请日：2005-09-13
申请人： Peter P Roller , Ya-Qui Long , Feng-Di T. Lung , C. Richter King , Dajun Yang , Johannes H. Voigt
发明人： Peter P Roller , Ya-Qui Long , Feng-Di T. Lung , C. Richter King , Dajun Yang , Johannes H. Voigt
IPC分类号： A61K38/12
CPC分类号： C07K7/06 , A61K38/00 , C07K7/56
摘要： A compound of formula: in which (i) aa1 is Adi and aa4 is Glu or (ii) each of aa1 and aa4 is Adi, L is sulfur, sulfoxide, oxygen or methylene, which compound (and its conjugates) bind to an SH2 domain in a protein comprising an SH2 domain, is non-phosphorylated, is redox-stable in vivo, is characterized by an IC50 in vivo of less than about 4.0 μM with respect to the SH2 domain in Grb2, and, upon binding to the SH2 domain of Grb2, has a turn conformation. A conjugate comprising a compound as described above and a carrier agent, a composition comprising (i) a compound or a conjugate as described above and (ii) a carrier, a method of inhibiting binding of an SH2 domain in a protein comprising an SH2 domain to a target protein in an animal, wherein the SH2 domain is contacted with a target protein-binding inhibiting effective amount of a compound or a conjugate as described above, and a method of synthesizing such conjugates.
摘要翻译：下式化合物：其中（i）aa 1是Adi，aa 4是Glu或（ii）aa 1和a a各自独立地选自 Ad1，L是硫，亚砜，氧或亚甲基，该化合物（及其缀合物）与包含SH2结构域的蛋白质中的SH2结构域结合，未被磷酸化，是氧化还原稳定的在体内，相对于Grb2中的SH2结构域，其体内IC 50小于约4.0μM，并且在结合到Grb2的SH2结构域时具有转向构象。包含如上所述的化合物和载体的缀合物，包含（i）如上所述的化合物或缀合物和（ii）载体的组合物，抑制包含SH2结构域的蛋白质中SH2结构域结合的方法涉及一种动物中的靶蛋白，其中SH2结构域与靶蛋白结合抑制有效量的上述化合物或结合物接触，以及合成这种缀合物的方法。

28. 发明授权

US06951915B2 Redox-stable, non-phosphorylated cyclic peptide inhibitors of SH2 domain binding to target protein, conjugates thereof, compositions and methods of synthesis and use 有权
标题翻译：与靶蛋白结合的SH2结构域的氧化还原稳定的非磷酸化环肽抑制剂，其结合物，组合物和合成和使用方法
公开(公告)号：US06951915B2
公开(公告)日：2005-10-04
申请号：US09998350
申请日：2001-11-30
申请人： Peter P. Roller , Ya-Qiu Long , Feng-Di T. Lung , C. Richter King , Dajun Yang
发明人： Peter P. Roller , Ya-Qiu Long , Feng-Di T. Lung , C. Richter King , Dajun Yang
IPC分类号： A61K38/00 , C07K7/06 , C07K7/56 , C07K7/00 , A61K31/00 , C07K7/50
CPC分类号： C07K7/06 , A61K38/00 , C07K7/56
摘要： A compound of formula: in which L is sulfur, sulfoxide, oxygen or methylene, and a compound of formula: in which (i) aa1 is Adi and aa4 is Glu or (ii) each of aa1 and aa4 is Adi, L is sulfur, sulfoxide, oxygen or methylene, which compounds (and their conjugates) bind to an SH2 domain in a protein comprising an SH2 domain, are non-phosphorylated, are redox-stable in vivo, are characterized by an IC50 in vivo of less than about 4.0 μM with respect to the SH2 domain in Grb2, and, upon binding to the SH2 domain of Grb2, have a turn conformation. A conjugate comprising a compound as described above and a carrier agent, a composition comprising (i) a compound or a conjugate as described above and (ii) a carrier, a method of inhibiting binding of an SH2 domain in a protein comprising an SH2 domain to a target protein in an animal, wherein the SH2 domain is contacted with a target protein-binding inhibiting effective amount of a compound or a conjugate as described above, and a method of synthesizing such conjugates.
摘要翻译：下式的化合物：其中L是硫，亚砜，氧或亚甲基，以及下式的化合物：其中（i）aa 1是Adi和aa 4是 Glu或（ii）aa 1和a 4中的每一个为Adi，L为硫，亚砜，氧或亚甲基，该化合物（及其共轭物）与SH2结合包含SH2结构域的未被磷酸化，在体内氧化还原稳定的蛋白质的结构域的特征在于体内相对于Grb2中的SH2结构域的小于约4.0μM的IC 50 并且在与Grb2的SH2结构域结合时具有转向构象。包含如上所述的化合物和载体的缀合物，包含（i）如上所述的化合物或缀合物和（ii）载体的组合物，抑制包含SH2结构域的蛋白质中SH2结构域结合的方法涉及一种动物中的靶蛋白，其中SH2结构域与靶蛋白结合抑制有效量的上述化合物或结合物接触，以及合成这种缀合物的方法。

29. 发明申请

US20170082607A9 MALARIA ANTIGEN SCREENING METHOD 审中-公开
公开(公告)号：US20170082607A9
公开(公告)日：2017-03-23
申请号：US13866116
申请日：2013-04-19
申请人： Joseph T. Bruder , Imre Kovesdi , Duncan L. McVey , Douglas E. Brough , C. Richter King , Denise Louise Doolan , Joao Carlos Aguair , Daniel John Carucci , Martha Sedegah , Walter R. Weiss , Keith Limbach
发明人： Joseph T. Bruder , Imre Kovesdi , Duncan L. McVey , Douglas E. Brough , C. Richter King , Denise Louise Doolan , Joao Carlos Aguair , Daniel John Carucci , Martha Sedegah , Walter R. Weiss , Keith Limbach
IPC分类号： G01N33/50
CPC分类号： G01N33/505
摘要： The invention provides a method of identifying an antigen from a pathogen or a disease antigen comprising the use of an adenoviral vector array comprising two or more different adenoviral vectors, wherein each adenoviral vector comprises a nucleic acid sequence encoding a different antigen of a pathogen. The adenoviral vectors are administered to antigen presenting cells (APCs) in vitro or to an animal in vivo. The immunogenicity of the antigen is measured by screening for an immune response from effector T lymphocytes in vitro and by screening for the absence of pathogen-induced disease onset in vivo.

30. 发明授权

US09254316B2 Adenoviral vector-based malaria vaccines 有权
标题翻译：基于腺病毒载体的疟疾疫苗
公开(公告)号：US09254316B2
公开(公告)日：2016-02-09
申请号：US13890422
申请日：2013-05-09
申请人： Joseph T. Bruder , C. Richter King , Thomas Richie , Keith Limbach , Denise Louise Doolan
发明人： Joseph T. Bruder , C. Richter King , Thomas Richie , Keith Limbach , Denise Louise Doolan
IPC分类号： A61K39/00 , A61K39/015 , C07H21/04 , C12N7/00
CPC分类号： A61K39/015 , A61K2039/53 , C12N7/00 , C12N2710/10043 , C12N2710/10343 , Y02A50/412
摘要： The invention provides a method of inducing an immune response against malaria in a mammal. The method comprises intramuscularly administering to a mammal a composition comprising a pharmaceutically acceptable carrier and either or both of (a) a first adenoviral vector comprising a nucleic acid sequence encoding a P. falciparum circumsporozoite protein (CSP) operably linked to a human CMV promoter, and/or (b) a second adenoviral vector comprising a nucleic acid sequence encoding a P. falciparum apical membrane antigen 1 (AMA-1) antigen operably linked to a human CMV promoter.
摘要翻译：本发明提供在哺乳动物中诱导针对疟疾的免疫应答的方法。该方法包括向哺乳动物施用包含药学上可接受的载体的组合物和（a）第一种腺病毒载体，其包含与人CMV启动子可操作地连接的编码恶性疟原虫环子孢子蛋白（CSP）的核酸序列，和/或（b）包含编码与人CMV启动子可操作地连接的恶性疟原虫顶端膜抗原1（AMA-1）抗原的核酸序列的第二腺病毒载体。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式